This Article Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal My Folders Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kobayashi, D. Articles by Satsuma, S. Search for Related Content PubMed PubMed Citation Articles by Kobayashi, D. Articles by Satsuma, S.

Cavernous lymphangioma of the leg in children treated by the injection of OK-432 after resection

Department of Orthopaedic Surgery, Kobe Children’s Hospital, 1-1-1 Takakuradai, Suma-ku, Kobe, Japan.

Correspondence should be sent to Dr D. Kobayashi.

We describe the treatment of three boys with cavernous lymphangioma of the legs. The suggested guidelines for treatment are extensive surgical resection, although complete resection is usually impossible, and approximately two weeks after the operation aspiration of serous fluid which has accumulated at the operation site, followed by injection of OK-432 (Picibanil). There was pyrexia and local inflammation for several days but the accumulation of serous fluid disappeared after the injection. There were no complications with no recurrence, joint contracture, or pain during a mean follow-up of 48 months (24 to 72).

We conclude that an injection of OK-432 after surgical resection of cavernous lymphangioma of the legs in children is an effective treatment.